The benefit of conversion therapy for patients with unresectable hepatocellular carcinoma receiving atezolizumab plus bevacizumab using newly established oncological resectability criteria in Japan
When feasible, conversion therapy should be considered to improve the prognosis of u-HCC patients treated with Atez/Bev. Moreover, oncological resectability criteria may provide a useful tool for investigators regarding conversion therapy.
Authors
- Hideki Kobara (ORCID: https://orcid.org/0000-0002-8508-827X)
- Tomotake Shirono (ORCID: https://orcid.org/0000-0002-2662-6779)
- Yasuto Takeuchi (ORCID: https://orcid.org/0000-0003-3261-0842)
- Takafumi Yamamoto (ORCID: https://orcid.org/0000-0002-9904-1894)
- Norikazu Tanabe (ORCID: https://orcid.org/0009-0005-9502-8886)
- Joji Tani (ORCID: https://orcid.org/0000-0001-8801-2505)
- Yuki Kanayama (ORCID: https://orcid.org/0000-0002-8639-5212)
- Taro Takami
- Takeshi Hatanaka (ORCID: https://orcid.org/0000-0003-3656-285X)
- Tetsuji Takayama (ORCID: https://orcid.org/0000-0002-0175-1573)
- Tetsu Tomonari
- Shigeo Shimose (ORCID: https://orcid.org/0000-0003-2068-8386)
- Ryu Sasaki (ORCID: https://orcid.org/0000-0002-0001-7377)
- Kyo Sasaki
- Motoyuki Otsuka (ORCID: https://orcid.org/0000-0003-2869-2881)
- Atsushi Naganuma (ORCID: https://orcid.org/0000-0003-0663-0102)
- Hiroki Kawashima (ORCID: https://orcid.org/0000-0002-3720-781X)
- Satoru Kakizaki (ORCID: https://orcid.org/0000-0002-1508-584X)
- Issei Saeki (ORCID: https://orcid.org/0000-0001-5885-5042)
- Takanori Ito (ORCID: https://orcid.org/0000-0002-2594-0854)
- Hideki Iwamoto (ORCID: https://orcid.org/0000-0001-5688-1335)
- Takumi Kawaguchi (ORCID: https://orcid.org/0000-0002-7064-4325)
- Sohji Nishina
Institutions
- Kurume University (JP)
- Yamaguchi University (JP)
- Kawasaki Medical School (JP)
- Kagawa University (JP)
- Okayama University Hospital (JP)
- National Hospital Organization Takasaki Medical Center (JP)
- Gunma Saiseikai Maebashi Hospital (JP)
- Nagasaki University (JP)
- Nagoya University (JP)
- Tokushima University (JP)
Publication Details
- Journal
- Hepatology International
- Published
- 2025-02-28
- DOI
- https://doi.org/10.1007/s12072-025-10781-y
- Citations
- 3
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 3.97